Key Takeaways
- Shares of Bloom Energy climbed 5% on Tuesday following congressional disclosure filings showing Nancy Pelosi acquired 15,000 shares and 200 call options in late July.
- Second-quarter revenue reached $1.07 billion, representing 166% year-over-year growth, while earnings per share of $0.78 exceeded analyst expectations of $0.39.
- The company increased its fiscal 2026 revenue outlook to a range of $3.9 billion to $4.2 billion, driven by AI data center infrastructure demand.
- Analyst sentiment remains at “Moderate Buy” with a mean price target of $248.05, suggesting approximately 21% potential upside.
- Potential headwinds include an elevated forward P/E ratio near 74, recent insider stock sales, and pending securities fraud litigation concerning alleged China supply chain misrepresentations.
Shares of Bloom Energy began Tuesday’s trading session at $213.55, marking a notable increase from Monday’s closing price of $204.02, following the release of congressional financial disclosure documents revealing that Nancy Pelosi’s household initiated a new investment in the fuel-cell technology provider.
By midday, the stock reached an intraday peak of $214.34, accompanied by trading volume exceeding 4 million shares.
Congressional filings made public on August 21 revealed two separate acquisitions of Bloom Energy Class A common stock executed on July 24 and July 28, representing a combined total of 15,000 shares. Additionally, the disclosure documented 200 call option contracts carrying a $100 strike price with a June 2027 expiration date.
According to the disclosure range requirements for congressional stock reports, the aggregate position value falls somewhere between approximately $4.25 million and $14.5 million.
This marks Pelosi’s initial documented transaction involving Bloom Energy securities.
Individual investors actively monitor Pelosi’s investment activities. A MarketWise survey conducted in July revealed that 34% of copycat traders follow her portfolio moves, ranking her just behind Warren Buffett at 35%. Portfolio tracking data from Quiver Quantitative indicates her holdings have delivered cumulative gains of 965% since 2014, significantly outpacing the S&P 500’s 313% return over the same period.
The same disclosure also documented Pelosi’s purchases of Intel shares and call options. Intel maintains a customer relationship with Bloom Energy, linking both investments to the broader AI infrastructure investment thesis.
Impressive Q2 Performance Also Drove Momentum
The disclosed Pelosi investment arrived alongside robust quarterly financial results. Bloom reported second-quarter revenue of $1.07 billion, representing 166% year-over-year expansion and marking the company’s first quarter surpassing the $1 billion revenue threshold. Earnings per share of $0.78 substantially exceeded the analyst consensus estimate of $0.39.
Company leadership elevated its fiscal 2026 revenue forecast to a range of $3.9 billion to $4.2 billion, projecting gross margin of 34% and earnings per share between $2.55 and $2.85.
Wall Street analysts project current-year revenue growth of approximately 103% to roughly $4.13 billion, with further expansion to over $6.77 billion anticipated in 2026.
The company’s expanded partnership with Oracle, potentially supporting up to 2.8 gigawatts of fuel-cell generating capacity, was highlighted as a primary growth catalyst. Management indicated that its AI infrastructure customer base now encompasses nearly two dozen clients and approximately 250 megawatts of capacity beyond the Oracle arrangement.
Valuation Concerns and Risk Factors
Notwithstanding the positive momentum, Bloom’s current valuation metrics appear elevated. The forward non-GAAP price-to-earnings multiple stands at approximately 74, substantially higher than the S&P 500’s average of roughly 20. The stock has already retreated from a year-to-date peak near $350.
The Wall Street analyst consensus stands at “Moderate Buy” with a mean price objective of $248.05. Among 26 analysts providing coverage, three assign a Strong Buy rating, 10 recommend Buy, 12 suggest Hold, and one rates the stock as Sell.
Recent insider sales introduce additional caution. Board member Jeffrey Immelt divested 30,000 shares on August 17 at an average transaction price of $238.91. Insider Satish Chitoori sold 2,053 shares on August 14. Aggregate insider dispositions over the most recent quarter totaled approximately 144,000 shares valued at $38.5 million.
Active securities fraud litigation alleging the company misrepresented its China supply chain dependencies continues, with a lead-plaintiff appointment deadline set for September 28.
JPMorgan maintains an Overweight rating on the stock with a $314 price target.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
